Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.70
-0.07 (-1.11%)
Apr 8, 2026, 9:55 AM EDT - Market open
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $416.76 million as of April 8, 2026. Its market cap has increased by 200.24% in one year.
Market Cap
416.76M
Enterprise Value
365.26M
1-Year Change
200.24%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $416.76M, an increase of 576.35%. That is a compound annual growth rate of 45.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 437.01M | 14.64% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 446.82M |
| Vanda Pharmaceuticals | 440.35M |
| Altimmune | 439.76M |
| Armata Pharmaceuticals | 437.76M |
| Sutro Biopharma | 425.94M |
| Aura Biosciences | 425.32M |
| XOMA Royalty | 412.05M |
| Century Therapeutics | 406.17M |